Market Overview:
The global decentralized/POC coagulation testing market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of thrombotic disorders, technological advancements in POC coagulation testing devices, and rising demand for point-of-care diagnostics. However, the high cost of POC coagulation testing devices may restrain the market growth during the forecast period. On the basis of type, the global decentralized/POC coagulation testing market is segmented into anti-coagulated plasma technology, whole blood specimen testing kits, and satellite anticoagulation therapy. The anti-coagulated plasma technology segment is expected to grow at a CAGR of 6% from 2018 to 2030 owing to its advantages such as accuracy and speed over other technologies.
Product Definition:
A decentralized/POC coagulation testing is a laboratory test that is used to determine the blood clotting time. This type of test is important because it can help to diagnose and monitor patients with bleeding disorders, thrombotic disorders, and liver diseases.
Anti-Coagulated Plasma Technology:
Anti-coagulated plasma technology is a new and emerging technique for the rapid testing of coagulation parameters in patients. Anti-coagulated plasma technology uses an advanced process to reduce the time required for testing, which makes it more accurate and reliable. This method also helps in reducing patient anxiety by providing results quickly after sample collection with no need to wait for test results as with other conventional techniques.
Whole Blood Specimen Testing Kits:
Whole blood specimen testing kits are used for the detection of coagulation factors in whole blood samples. These tests are considered as one of the most important and commonly performed laboratory tests across all medical specialties. The rising prevalence of hematological malignancies, such as acute leukemia and chronic lymphatic leukemia, is expected to serve this market with growth opportunities over the forecast period.
Application Insights:
Based on application, the global market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment dominated the overall market in terms of revenue in 2017 owing to factors such as increasing prevalence of chronic diseases and rising geriatric population across the globe. Moreover, an increase in number of surgeries has led to increased demand for coagulation testing devices at hospitals.
The other segment includes laboratories and patient care centers that offer outpatient services for the diagnosis of blood disorders or conditions requiring anticoagulant therapy. These facilities are equipped with automated analyzers that perform tests rapidly without operator intervention; these factors contribute towards a significant share by way of revenue during any given year. For instance, Dade Behring Inc., a ULC company based in Canada provides Decentralized/Point-of-Care Coagulation Testing solutions which help healthcare providers detect & treat bleeding quickly & efficiently while reducing exposure to risk by minimizing handling procedures during testing or treatment decisions (2017).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, such as Prodigy Sciences, Inc.; Siemens Healthcare; and BioXpert International GmbH. The region is expected to maintain its dominance throughout the forecast period owing to factors such as favorable reimbursement policies and increasing geriatric population prone to bleeding disorders.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to rising healthcare expenditure by governments along with an increase in awareness regarding POC testing services for patients living outside hospitals & clinics setting up outpatient centers & urgent care centers. Moreover, growing penetration of advanced medical devices coupled with favorable government initiatives are also contributing towards market growth in this region.
Growth Factors:
- Increasing incidence of thrombotic disorders: The global prevalence of thrombotic disorders is increasing at a significant rate. This is primarily attributed to the changing lifestyle and dietary habits, growing aging population, and rising incidence of obesity and diabetes. All these factors are collectively contributing to the increasing number of patients with thrombotic disorders. This in turn is fueling the demand for decentralized/POC coagulation testing products and services, thereby driving the growth of this market.
- Technological advancements in coagulation testing: The technological advancements in coagulation testing are aiding in the development of novel POC tests that are easier to use and provide faster results than traditional methods. This is resulting in an increase in adoption rates of POC tests among clinicians, which is propelling the growth prospects for this market segmentation.
- Growing demand for point-of-care diagnostics: The growing demand for point-of-care diagnostics across all healthcare settings is providing a major impetus to the growth prospects for decentralized/POC coagulation testing products and services worldwide. Rising patient awareness about early diagnosis and treatment options has led to an increased demand for rapid diagnostic tests that can provide accurate results within minutes or hours instead of days or weeks required by conventional laboratory methods used for diagnosis purposes .This factor is likely to fuel further growth prospects for decentralized/POC coagulation testing over next few years.. 4)Rising geriatric population
Scope Of The Report
Report Attributes
Report Details
Report Title
Decentralized/POC Coagulation Testing Market Research Report
By Type
Anti-Coagulated Plasma Technology, Whole Blood Specimen Testing Kits, Satellite Anticoagulation Therapy
By Application
Hospitals, Ambulatory Surgical Centers, Others
By Companies
Roche Diagnostics, Abbott Laboratories, Biosite Diagnostic, Medtronic, Trinity Biotech, Polartechnics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Decentralized/POC Coagulation Testing Market Report Segments:
The global Decentralized/POC Coagulation Testing market is segmented on the basis of:
Types
Anti-Coagulated Plasma Technology, Whole Blood Specimen Testing Kits, Satellite Anticoagulation Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostics
- Abbott Laboratories
- Biosite Diagnostic
- Medtronic
- Trinity Biotech
- Polartechnics
Highlights of The Decentralized/POC Coagulation Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anti-Coagulated Plasma Technology
- Whole Blood Specimen Testing Kits
- Satellite Anticoagulation Therapy
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Decentralized/POC Coagulation Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Decentralized/POC Coagulation Testing is a type of laboratory testing that uses decentralized technology to collect and analyze blood samples. This testing method allows for more accurate results because it does not rely on centralized servers or laboratories.
Some of the key players operating in the decentralized/poc coagulation testing market are Roche Diagnostics, Abbott Laboratories, Biosite Diagnostic, Medtronic, Trinity Biotech, Polartechnics.
The decentralized/poc coagulation testing market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Decentralized/POC Coagulation Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Decentralized/POC Coagulation Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Decentralized/POC Coagulation Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Decentralized/POC Coagulation Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Decentralized/POC Coagulation Testing Market Size & Forecast, 2018-2028
4.5.1 Decentralized/POC Coagulation Testing Market Size and Y-o-Y Growth
4.5.2 Decentralized/POC Coagulation Testing Market Absolute $ Opportunity
Chapter 5 Global Decentralized/POC Coagulation Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Decentralized/POC Coagulation Testing Market Size Forecast by Type
5.2.1 Anti-Coagulated Plasma Technology
5.2.2 Whole Blood Specimen Testing Kits
5.2.3 Satellite Anticoagulation Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Decentralized/POC Coagulation Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Decentralized/POC Coagulation Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Decentralized/POC Coagulation Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Decentralized/POC Coagulation Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Decentralized/POC Coagulation Testing Analysis and Forecast
9.1 Introduction
9.2 North America Decentralized/POC Coagulation Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Decentralized/POC Coagulation Testing Market Size Forecast by Type
9.6.1 Anti-Coagulated Plasma Technology
9.6.2 Whole Blood Specimen Testing Kits
9.6.3 Satellite Anticoagulation Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Decentralized/POC Coagulation Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Decentralized/POC Coagulation Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Decentralized/POC Coagulation Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Decentralized/POC Coagulation Testing Market Size Forecast by Type
10.6.1 Anti-Coagulated Plasma Technology
10.6.2 Whole Blood Specimen Testing Kits
10.6.3 Satellite Anticoagulation Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Decentralized/POC Coagulation Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Decentralized/POC Coagulation Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Decentralized/POC Coagulation Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Decentralized/POC Coagulation Testing Market Size Forecast by Type
11.6.1 Anti-Coagulated Plasma Technology
11.6.2 Whole Blood Specimen Testing Kits
11.6.3 Satellite Anticoagulation Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Decentralized/POC Coagulation Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Decentralized/POC Coagulation Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Decentralized/POC Coagulation Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Decentralized/POC Coagulation Testing Market Size Forecast by Type
12.6.1 Anti-Coagulated Plasma Technology
12.6.2 Whole Blood Specimen Testing Kits
12.6.3 Satellite Anticoagulation Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Decentralized/POC Coagulation Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Decentralized/POC Coagulation Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Decentralized/POC Coagulation Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Decentralized/POC Coagulation Testing Market Size Forecast by Type
13.6.1 Anti-Coagulated Plasma Technology
13.6.2 Whole Blood Specimen Testing Kits
13.6.3 Satellite Anticoagulation Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Decentralized/POC Coagulation Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Decentralized/POC Coagulation Testing Market: Competitive Dashboard
14.2 Global Decentralized/POC Coagulation Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche Diagnostics
14.3.2 Abbott Laboratories
14.3.3 Biosite Diagnostic
14.3.4 Medtronic
14.3.5 Trinity Biotech
14.3.6 Polartechnics
